Cargando…
Identification of several plasma proteins whose levels in colorectal cancer patients differ depending on outcome
Colorectal cancer (CRC) stands for 10% of the worldwide cancer burden and has recently become the second most common cause of cancer death. The 5‐year survival rate depends mainly on stage at diagnosis. Mass spectrometric proteomic analysis is widely used to study the plasma proteome, which is compl...
Autores principales: | Holm, Matilda, Joenväärä, Sakari, Saraswat, Mayank, Mustonen, Harri, Tohmola, Tiialotta, Ristimäki, Ari, Renkonen, Risto, Haglund, Caj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996405/ https://www.ncbi.nlm.nih.gov/pubmed/32123817 http://dx.doi.org/10.1096/fba.2019-00062 |
Ejemplares similares
-
Plasma protein expression differs between colorectal cancer patients depending on primary tumor location
por: Holm, Matilda, et al.
Publicado: (2020) -
Colorectal cancer patients with different C-reactive protein levels and 5-year survival times can be differentiated with quantitative serum proteomics
por: Holm, Matilda, et al.
Publicado: (2018) -
Comparative proteomic profiling of the serum differentiates pancreatic cancer from chronic pancreatitis
por: Saraswat, Mayank, et al.
Publicado: (2017) -
Quantitative glycoproteomics of human milk and association with atopic disease
por: Holm, Matilda, et al.
Publicado: (2022) -
Quantitative bile and serum proteomics for the screening and differential diagnosis of primary sclerosing cholangitis
por: Holm, Matilda, et al.
Publicado: (2022)